Tick the questions to print

All of this cancer's questions start ticked. Untick what does not apply; ticks are kept in this browser. .

Newly diagnosed: What is my exact diagnosis, stage, and grade, and which tests established them?

Newly diagnosed: Which biomarkers have been tested on my tumour (for example Growth factor pathway gene expression, EGFR expression), and what were the results?

Newly diagnosed: Which subtype is my cancer, and does that change the recommended treatment?

Newly diagnosed: Is germline (inherited) genetic testing recommended for me or my family?

Stage II to III: For my situation (stage ii to iii), which of the standard options do you recommend and why?

Stage II to III: Am I a candidate for Pembrolizumab, and what side effects should I expect?

Stage II to III: How do the results of KEYNOTE-522 apply to someone like me?

Any stage: Would a second opinion at a high-volume centre change anything, and can you help arrange it?

Any stage: What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?

Appointment sheet

Basal-like 2 triple-negative breast cancer (BL2)

Prepared with OnCo (onco.cc/prep/tnbc-basal-like-2/). Orientation, not medical advice; your team knows your case.

My details

Name

Date of appointment

Hospital and clinician

Who is coming with me

What I know, what is unclear, changes to discuss

Saved in this browser

What I know so far

What is unclear to me

Changes since last time

My questions

9 on the sheet

Newly diagnosed

1.What is my exact diagnosis, stage, and grade, and which tests established them?
2.Which biomarkers have been tested on my tumour (for example Growth factor pathway gene expression, EGFR expression), and what were the results?
3.Which subtype is my cancer, and does that change the recommended treatment?
4.Is germline (inherited) genetic testing recommended for me or my family?

Stage II to III

5.For my situation (stage ii to iii), which of the standard options do you recommend and why?
6.Am I a candidate for Pembrolizumab, and what side effects should I expect?
7.How do the results of KEYNOTE-522 apply to someone like me?

Any stage

8.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
9.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?

The words I may hear

Basal-like breast cancer: Basal-like is a breast cancer subtype defined by the genes its cells switch on, which resemble the basal cells lining the milk ducts.
Pathologic complete response (pCR): No invasive cancer left in the breast and lymph nodes when the surgeon removes the tissue after pre-surgery treatment.

Tests and results to bring

Biomarker results to ask for: Growth factor pathway gene expression (research), EGFR expression.

Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.

The treatments I may be offered

Stage II to III: As for triple-negative disease (KEYNOTE-522 regimen); the low pathological complete response rate in this subtype is a research observation, not a reason to change treatment. (KEYNOTE-522, Pembrolizumab)

From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.

Answers and next steps

Saved in this browser

What I was told

Agreed next steps, dates and who to call

Tick the questions to print